Digital Pathology Market: Information by Product (Scanners, Software, Communication Systems, Storage Systems), Type, Application, End-User, and Region — Forecast till 2029

Request Free Sample Report

Report Description

Global Statistics Representing Digital Pathology Market Scenario

Digital pathology is the process of transforming glass slides into digital slides that can be viewed, handled, and interpreted on a computer monitor. In 2017, the U.S. Food and Drug Administration approved the marketing of the first full slide imaging system for digital pathology, gaining recognition, authentication, and worldwide acceptance of this technology. The increasing implementation of digital pathology in education and training and the integration of AI into digital pathology systems are significant factors fostering market growth. The U.S., the U.K., and Germany are presently the prominent markets for digital pathology.

The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast study period.

Digital-Pathology-Market

Increasing Focus on Research and Development, and Prevalence of Cancer

The World Health Organization reports that an unprecedented 9.6 million deaths and 18.1 million new cancer cases were recorded worldwide in 2018. The number of cancer cases is rising due to the increasing aging population coupled with sedentary lifestyles globally. According to the UN organization, the number of older persons is predicted to reach nearly 2.1 billion by 2050.

Preclinical research using an animal model and clinical trials play a vital role in determining the drug's safety and efficacy. Digital pathology helps to reduce the risk of error, store drug data, incorporate data into electronic health records (EHRs), and assess the patient's reaction to a specific medication, etc. Increasing emphasis on drug development and drug discovery research and development is contributing to an increase in the number of clinical and preclinical trials that are boosting the growth of the global digital pathology industry.

Digital-Pathology-Market-Growth

Increased emphasis on improving the productivity of the workflow and demand for faster diagnostic tools for chronic diseases such as cancer have been key drivers of development. Medical urgency to implement digital pathology is expected to stimulate the prevalence of chronic conditions to boost current inadequate diagnostic imaging interventions for patients and to reduce high costs associated with traditional diagnoses. In addition, the burgeoning geriatric population vulnerable to chronic conditions is also expected to raise demand for advanced technical diagnostic procedures. The high mortality rate can be due to chronic diseases, according to a report published in Medscape.

Technological Progressions to Provide an Impetus to Market Growth  

Rapid technological advancements in digital pathology systems are predicted to contribute immensely to market growth. Digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications, are also determinants driving the market growth. Whole slide imaging has various advantages compared to traditional light microscopes, which are expected to bring forth lucrative opportunities for the market during the forecast period.

Furthermore, developments like microarrays and the introduction of a wide variety of predictive models like hybrid models and API algorithms are expected to accelerate the market growth for digital image analysis. Growing preference for computer-aided diagnosis that combines image processing, physics, mathematics, and computational algorithms, facilitates efficient disease detection and helps to determine anatomical structures of interest and measure disease progression as well as risk assessment.

Segmental Analysis

Chronic Disease’s Prevalence to Drive the Disease Diagnostic Segment Growth

The disease diagnostic segment is expected to experience the fastest growth during the forecast period, owing to the rising prevalence of chronic diseases. Digital pathology includes various technologies for the diagnosis of diseases, including laboratory management systems, digital dictation, dashboards and workflow control, digital image analysis, electronic specimen labeling, and monitoring, and synoptic reporting tools. Manufacturers are focusing on developing novel and rapid diagnostic techniques. Digital technology help to enhance every diagnostic phase and make it easy to exchange information in inter departments or intra departments.

Application of Digital Pathology for Drug Discovery Studies

The pharmaceutical and biotechnology companies segment accounted for the largest share of the global demand for digital pathology by end-user in 2019. Factors leading to this segment's large share and fast growth rate include rising use of digital pathology for drug discovery studies and drug toxicology research. Moreover, biotechnology corporations also use digital pathology to develop biobanking, biopharmaceutical trials, molecular assays, and personalized medicine.

Regional Analysis

The regional analysis has been made considering the trends of the digital pathology in the regions of North America, Europe, Asia -Pacific, South America, and the Middle East and Africa.

North-America-Lead-Digital-Pathology-Market

Digital Pathology Usage in Education and Training in North America

In terms of sales, North America holds the largest market share due to continuous R&D investments, supporting government initiatives relating to technologically advanced systems, growing digital imaging adoption, and the involvement of prominent players. Accelerated use of digital pathology for diagnosis of disease coupled with favorable reimbursement policies in the U.S., enhancing the standard of diagnosis of cancer, is anticipated to accelerate the regional growth. The increasing implementation of digital pathology in education and training and the integration of AI into digital pathology systems are primary factors that are boosting the regional market growth.

Asia-Pacific’s Increasing Healthcare Expenditure

Asia-Pacific is expected to grow at the fastest pace during the forecast period due to growing digital imaging penetration in emerging economies, increasing healthcare expenditure, medical innovation, and demand for cost-effective digital pathology. In light of the elevated rates of cancer cases,  the Asia-Pacific healthcare industry has been affected strongly. Growing demand for innovative treatment options, better patient care facilities, and reduced laboratory expenditures are also expected to push demand further.

Competitive Landscape

The market for digital pathology is in the growth phase, with prominent players taking efforts to differentiate their products from the other market players, and companies are adopting strategies such as the development of new technology, products, and collaboration with the other players and research institutes. Companies are often involved in awareness-raising initiatives with end-users to gain an advantage over the competition. Some of the notable market players in the market are:

  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd
  • 3DHISTECH
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm A/S.
  • Corista
  • Indica Labs
  • Objective Pathology Services
  • Sectra AB
  • OptraSCAN
  • Glencoe Software
  • Inspirata, Inc.
  • Mikroscan Technologies
  • Proscia Inc.
  • Kanteron Systems

Recent Developments

  • In March 2020, Pathcore announced to offer PathcoreFlow platform at no cost during the COVID-19 crisis to enable remote teams in pathology to continue the work and research from the safety of their own homes.
  • In February 2019, Neuberg Diagnostics and OptraSCAN Inc. launched a new joint venture called Neuberg DIGIPATH, a Global TELEPath Network for the pathology community in the UAE, India, and South Africa, thereby offering advanced and affordable digital pathology solutions.
  • In January 2019, XIFIN, Inc. launched VisualStrata, the only precision medicine informatics platform that curates and visualizes diagnostic, clinical and financial data to document the patient journey through diagnosis, treatment, and outcomes
  • In March 2018, F. Hoffmann-La Roche Ltd launched VENTANA DP 200 optical pathology slide scanner.

Digital Pathology Market Segmentation

By Product

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems

By Type

  • Human Pathology
  • Veterinary Pathology

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Teleconsultation
  • Training and Education

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic and Research Institutes

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • Central, South America, and the Caribbean
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast study period.
growing digital imaging penetration in emerging economies, increasing healthcare expenditure, medical innovation is the key factors expected to drive Digital Pathology Market during the forecast period.
North America is expected to hold the highest market share in Digital Pathology Market.
Leica Biosystems, Koninklijke Philips N.V., 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm A/S., Corista, Indica Labs are the top players in Digital Pathology Market.
In 2019 Global Digital Pathology Market was valued at USD 541.61 million.
Pharmaceutical and Biotechnology Segment is expected to be the leading segment in Digital Pathology Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

Global Statistics Representing Digital Pathology Market Scenario

Digital pathology is the process of transforming glass slides into digital slides that can be viewed, handled, and interpreted on a computer monitor. In 2017, the U.S. Food and Drug Administration approved the marketing of the first full slide imaging system for digital pathology, gaining recognition, authentication, and worldwide acceptance of this technology. The increasing implementation of digital pathology in education and training and the integration of AI into digital pathology systems are significant factors fostering market growth. The U.S., the U.K., and Germany are presently the prominent markets for digital pathology.

The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast study period.

Digital-Pathology-Market

Increasing Focus on Research and Development, and Prevalence of Cancer

The World Health Organization reports that an unprecedented 9.6 million deaths and 18.1 million new cancer cases were recorded worldwide in 2018. The number of cancer cases is rising due to the increasing aging population coupled with sedentary lifestyles globally. According to the UN organization, the number of older persons is predicted to reach nearly 2.1 billion by 2050.

Preclinical research using an animal model and clinical trials play a vital role in determining the drug's safety and efficacy. Digital pathology helps to reduce the risk of error, store drug data, incorporate data into electronic health records (EHRs), and assess the patient's reaction to a specific medication, etc. Increasing emphasis on drug development and drug discovery research and development is contributing to an increase in the number of clinical and preclinical trials that are boosting the growth of the global digital pathology industry.

Digital-Pathology-Market-Growth

Increased emphasis on improving the productivity of the workflow and demand for faster diagnostic tools for chronic diseases such as cancer have been key drivers of development. Medical urgency to implement digital pathology is expected to stimulate the prevalence of chronic conditions to boost current inadequate diagnostic imaging interventions for patients and to reduce high costs associated with traditional diagnoses. In addition, the burgeoning geriatric population vulnerable to chronic conditions is also expected to raise demand for advanced technical diagnostic procedures. The high mortality rate can be due to chronic diseases, according to a report published in Medscape.

Technological Progressions to Provide an Impetus to Market Growth  

Rapid technological advancements in digital pathology systems are predicted to contribute immensely to market growth. Digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications, are also determinants driving the market growth. Whole slide imaging has various advantages compared to traditional light microscopes, which are expected to bring forth lucrative opportunities for the market during the forecast period.

Furthermore, developments like microarrays and the introduction of a wide variety of predictive models like hybrid models and API algorithms are expected to accelerate the market growth for digital image analysis. Growing preference for computer-aided diagnosis that combines image processing, physics, mathematics, and computational algorithms, facilitates efficient disease detection and helps to determine anatomical structures of interest and measure disease progression as well as risk assessment.

Segmental Analysis

Chronic Disease’s Prevalence to Drive the Disease Diagnostic Segment Growth

The disease diagnostic segment is expected to experience the fastest growth during the forecast period, owing to the rising prevalence of chronic diseases. Digital pathology includes various technologies for the diagnosis of diseases, including laboratory management systems, digital dictation, dashboards and workflow control, digital image analysis, electronic specimen labeling, and monitoring, and synoptic reporting tools. Manufacturers are focusing on developing novel and rapid diagnostic techniques. Digital technology help to enhance every diagnostic phase and make it easy to exchange information in inter departments or intra departments.

Application of Digital Pathology for Drug Discovery Studies

The pharmaceutical and biotechnology companies segment accounted for the largest share of the global demand for digital pathology by end-user in 2019. Factors leading to this segment's large share and fast growth rate include rising use of digital pathology for drug discovery studies and drug toxicology research. Moreover, biotechnology corporations also use digital pathology to develop biobanking, biopharmaceutical trials, molecular assays, and personalized medicine.

Regional Analysis

The regional analysis has been made considering the trends of the digital pathology in the regions of North America, Europe, Asia -Pacific, South America, and the Middle East and Africa.

North-America-Lead-Digital-Pathology-Market

Digital Pathology Usage in Education and Training in North America

In terms of sales, North America holds the largest market share due to continuous R&D investments, supporting government initiatives relating to technologically advanced systems, growing digital imaging adoption, and the involvement of prominent players. Accelerated use of digital pathology for diagnosis of disease coupled with favorable reimbursement policies in the U.S., enhancing the standard of diagnosis of cancer, is anticipated to accelerate the regional growth. The increasing implementation of digital pathology in education and training and the integration of AI into digital pathology systems are primary factors that are boosting the regional market growth.

Asia-Pacific’s Increasing Healthcare Expenditure

Asia-Pacific is expected to grow at the fastest pace during the forecast period due to growing digital imaging penetration in emerging economies, increasing healthcare expenditure, medical innovation, and demand for cost-effective digital pathology. In light of the elevated rates of cancer cases,  the Asia-Pacific healthcare industry has been affected strongly. Growing demand for innovative treatment options, better patient care facilities, and reduced laboratory expenditures are also expected to push demand further.

Competitive Landscape

The market for digital pathology is in the growth phase, with prominent players taking efforts to differentiate their products from the other market players, and companies are adopting strategies such as the development of new technology, products, and collaboration with the other players and research institutes. Companies are often involved in awareness-raising initiatives with end-users to gain an advantage over the competition. Some of the notable market players in the market are:

  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd
  • 3DHISTECH
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm A/S.
  • Corista
  • Indica Labs
  • Objective Pathology Services
  • Sectra AB
  • OptraSCAN
  • Glencoe Software
  • Inspirata, Inc.
  • Mikroscan Technologies
  • Proscia Inc.
  • Kanteron Systems

Recent Developments

  • In March 2020, Pathcore announced to offer PathcoreFlow platform at no cost during the COVID-19 crisis to enable remote teams in pathology to continue the work and research from the safety of their own homes.
  • In February 2019, Neuberg Diagnostics and OptraSCAN Inc. launched a new joint venture called Neuberg DIGIPATH, a Global TELEPath Network for the pathology community in the UAE, India, and South Africa, thereby offering advanced and affordable digital pathology solutions.
  • In January 2019, XIFIN, Inc. launched VisualStrata, the only precision medicine informatics platform that curates and visualizes diagnostic, clinical and financial data to document the patient journey through diagnosis, treatment, and outcomes
  • In March 2018, F. Hoffmann-La Roche Ltd launched VENTANA DP 200 optical pathology slide scanner.

Digital Pathology Market Segmentation

By Product

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems

By Type

  • Human Pathology
  • Veterinary Pathology

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Teleconsultation
  • Training and Education

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic and Research Institutes

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • Central, South America, and the Caribbean
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast study period.
growing digital imaging penetration in emerging economies, increasing healthcare expenditure, medical innovation is the key factors expected to drive Digital Pathology Market during the forecast period.
North America is expected to hold the highest market share in Digital Pathology Market.
Leica Biosystems, Koninklijke Philips N.V., 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm A/S., Corista, Indica Labs are the top players in Digital Pathology Market.
In 2019 Global Digital Pathology Market was valued at USD 541.61 million.
Pharmaceutical and Biotechnology Segment is expected to be the leading segment in Digital Pathology Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.
Table of Content Download Sample

Copyright . All rights Reserved By Straits Research